Yukai Wang

Mr. Yukai Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
JZJinyu Zhang
Jinyu Zhang
YWYukai Wang
Yukai Wang
CCChaoyi Chen
Chaoyi Chen
XLXinran Liu
Xinran Liu
Xueqi LiuXueqi Liu
Xueqi Liu
YWYonggui Wu
Yonggui Wu

3 January 2026 in Inflammation
Verified
Journal Article
Open access
PDF file
ZHZiyun Hu
Ziyun Hu
YMYu Ma
Yu Ma
YWYukai Wang
Yukai Wang
JWJIngjing Wang
JIngjing Wang
XLXinran Liu
Xinran Liu
YWYonggui Wu
Yonggui Wu
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Given the limited therapeutic options, identifying novel differentially expressed genes and therapeutic targets is crucial for DN. We performed transcriptome sequencing of kidney tissue from DN patients and applied bioinformatics analyses to identify dysregulated pathways and candidate genes. Transcriptomic analysis revealed significant enrichment of the necroptosis pathway in DN kidney tissues, with Z-DNA binding protein 1 (ZBP1) showing the most pronounced differential expression among pathway-associated genes. Clinical and pathological data were collected from DN patients to evaluate the correlation between ZBP1 expression and key indicators of renal function and injury, thereby assessing its association with DN progression. Our results indicate that ZBP1 expression was significantly upregulated in DN kidney tissues compared to normal peritumour tissue, and correlated with renal tubule injury and renal function. Functional studies demonstrated that ZBP1 knockdown attenuated necroptosis, tubular injury, inflammation, and fibrosis in both db/db mice and high glucose/advanced glycation end products (HG/AGEs)-stimulated MTECs (mouse renal tubular epithelial cells). Mechanistically, ZBP1 directly interacts with receptor interacting protein kinase 3 (RIPK3) to promote necroptotic cell death. Furthermore, we identified ETS proto-oncogene 1 (ETS1) as a transcriptional activator of ZBP1 under HG conditions. In summary, this study identifies ZBP1 as a key mediator of tubular injury, inflammation and fibrosis in DN via RIPK3-dependent necroptosis, highlighting its potential as a therapeutic target.


15 July 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
LGLi Gao
Li Gao
JZJunsheng Zhang
Junsheng Zhang
CCChaoyi Chen
Chaoyi Chen
SZSai Zhu
Sai Zhu
XWXianglong Wei
Xianglong Wei
YWYonggui Wu
Yonggui Wu
Acute kidney injury (AKI) is characterized by a rapid decline in renal function. In severe or recurrent cases, AKI can progress to chronic kidney disease (CKD), marked by renal inflammation and fibrosis. Despite the severity of these outcomes, early-stage diagnostic tools and pharmacological interventions for AKI-to-CKD progression remain limited. In this study, we examined circular RNA (circRNA) expression profiles in mouse renal cortex tissues 14 days after ischemia/reperfusion (I/R) injury using circRNA-Seq. The renal biopsy samples of patients after AKI exhibited reduced CircNSD1 expression, which was inversely associated with inflammation and fibrosis. Overexpression of CircNSD1 attenuated ferroptosis in vivo and in vitro, while slowing AKI-to-CKD progression. Mechanistically, CircNSD1 downregulated ACSL4 and SLC39A14 expression through histone H3 lysine 36 (H3K36) methylation, a critical pathway regulating ferroptosis after AKI or hypoxia/reoxygenation (H/R) injury. Furthermore, we identified that CircNSD1 encoded a NSD1-916aa peptide, which may functionally contribute to its observed effect. Collectively, these findings demonstrated that Circ NSD1 may serve as a diagnostic and therapeutic target for early detection of AKI-to-CKD transition.